Erin VanDyke Congratulates IU Health on Joining the NBCA COE Program
Erin VanDyke, PA-C, MPAS, Vice President of National Blood Clot Alliance Centers of Excellence, reposted from NBCA on LinkedIn:
”Congrats to the VTE teams at IU Health and welcome to the National Blood Clot Alliance COE program!!
We are so excited for this partnership and for the VTE excellence this team brings to Indiana.
Great things happen when patients, clinicians, and community come together!
Looking forward to the path forward..together!!
NBCA posted on LinkedIn:
”Great news for blood clot patients in Indiana!
The National Blood Clot Alliance (NBCA) is proud to announce IU Health Methodist Hospital in Indianapolis as the state’s first NBCA Venous Thromboembolism (VTE) Center of Excellence™, joining a growing national network dedicated to excellence in the prevention, diagnosis, and treatment of blood clots.
This recognition reflects the outstanding multidisciplinary efforts across IU Health, including teams at both Methodist and University hospitals. Their collaboration has been instrumental in achieving the high standards required for this designation. As IU Health prepares to integrate these hospitals into a single, state-of-the-art facility, this designation will carry forward — underscoring a continued commitment to excellence in VTE care.
‘This designation reflects our team’s tireless efforts to implement timely diagnosis, appropriate treatment, and long-term prevention strategies for patients at risk of blood clots,’ said Paul Haste, MD. ‘We could not be more excited to partner with NBCA to continue this important work improving care for patients throughout the state of Indiana.’
Congratulations to IU Health Methodist Hospital for this well-deserved honor.”
Stay updated on the latest news in the field of hematology with Hemostasis Today.
-
Jul 31, 2025, 16:43Jason S Knight: Antiphospholipid Syndrome Review
-
Jul 31, 2025, 16:28William McKeown: Once or Twice Weekly Altuvoct? Insights
-
Jul 31, 2025, 16:07Thomas Reiser: Submit Your Research to JTH and RPTH
-
Jul 31, 2025, 15:56eJHaem Publication and MATRON Audit Spotlight Gaps in Pulmonary Embolism Care for Pregnant Patients
-
Jul 31, 2025, 15:50Alfadil Haroon on Inherited Platelet Disorders: Know The Basics
-
Jul 31, 2025, 16:12Samin Mohsenian Shares the Final Open Access Version: Ob/Gyn Complications and Congenital Fibrinogen Disorders
-
Jul 31, 2025, 15:45Tzu-Fei Wang: To Anticoagulate or Not To Anticoagulate—That Is The Question
-
Jul 31, 2025, 15:12Wolfgang Miesbach: Protecting Liver Health in Bleeding Disorders
-
Jul 30, 2025, 16:24Cedric Hermans Invites You to Explore Hematologie Edition 2025 Nº 04
-
Jul 30, 2025, 15:53Robert Sidonio on the Role of aPCC in Patients Receiving Emicizumab Prophylaxis
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 31, 2025, 15:37Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab
-
Jul 28, 2025, 12:53Zambia’s Hemophilia Prophylaxis Success
-
Jul 26, 2025, 16:14Cesar Garrido: Forging Strong Partnerships on WHA78 ''Global Health Equity'' Event
-
Jul 23, 2025, 15:34Don't Miss the Hemophilia B Virtual Event on July 29 – Sign Up Now!
-
Jul 23, 2025, 11:05Haemnet Gives Voice to Parents Facing the Challenges of Childhood Bleeding Disorders